UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade
University of California, Davis
University of California, Davis
Providence Health & Services
Stanford University
Ludwig Institute for Cancer Research
Stanford University
Alliance for Clinical Trials in Oncology
NYU Langone Health
University of Utah
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)